Viewing Study NCT04422366


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-25 @ 2:04 PM
Study NCT ID: NCT04422366
Status: RECRUITING
Last Update Posted: 2024-06-07
First Post: 2020-05-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module